Nasal cytology in southwest metropolitan Mexico City inhabitants: a pilot intervention study. by Calderon-Garcidueñas, L & Roy-Ocotla, G
Nasal Cytology in Southwest Metropolitan
Mexico City Inhabitants: A Pilot Intervention
Study
Lilian Calderon-Garciduefias 1 and Guadalupe Roy-Ocotla2
1Centro Nacional de Investigaci6n en Calidad Ambiental Cenica, Mexico City, Mexico;
2Centro de Ciencias de La Atmosfera, National University of Mexico, Mexico City, Mexico
..S..,,.,.,.x..ee......... MoUtls.W~ Metropolitan Mexico City (MMC) is one
""'-X.S. .. of the most polluted urban areas in the
::r:40y :w i:hK ::SSS:O: world, and southwest metropolitan Mexico
City (SWM MC) cannot absorb large
SWMMCeeX pO iS~p SS- '''' amounts of pollutant emissions without
ti--;&_m|_scoes_0 ar- exceeding health-based air quality stan-
'Sdards. We previously reported the devel-
ofs 4ult indMduals mow-ays of opment of nasal mucosa dysplasia in
.17.64% and 78.72% of <30-day and >60-
day SWMMC residents and suggested that
fSS essss ozone, the most important photochemical
ulatio*i. cbss1 t " S pollutant in SWMMC, could play a syner-
dk4,-, t.rial,{' 17' ''' SSlt S_f tiS ' gistic role in combination with other toxic
o. .:.:.:and potential carcinogens (1). The present
--Vitamm.Asssss- WleXOIU.e ffi ssss sss ste"w study was designed to explore if chemopre-
*}SSt. . "."SiZsse .vention,
both secondary and tertiary (2), is
capable of halting or delaying the develop-
ssie2ul - E^sN2-2 sss ment of nasal mucosa dysplastic lesions in
w2Siasw 'SS' 'S~d ots°hc SWMMC inhabitants. Accordingly, a ran-
domized, double-blind, placebo-controlled
,anon ,e.o''.'.'.,,,.,.', 9 study using low oral doses of vitamin A
..xid*ldeuts (5000 LU), vitamin E (100 LU), vitamins A
.XOSP°. o}- and E (5000 IU and 100 IU), and
~carotene (16 mg) was undertaken.
-----.,-:--,,,,|,,,,,0, ieo*scth4 4y":spl The choice of both vitamins and pre- pwdktwe 3 f taESiWMMC ut cursor was made on the basis of previous
°°au°tabss s ssss oposed OJss ss sa reports (2). Briefly, vitamin A allows nor-
X. mal growth and epithelial differentiation,
and in numerous studies vitamin A and
carotene have been used to induce remis-
-'-'S viii sion and/or inhibition of the development
y.. of oral leukoplakias (3-5). In betel quid
1ion-'term of9f - he*s59! e chewers, the clinical trials varied in length
X_^ee from 3, 6, and 14 months, and variable
-on PtdYF i~ul cy~ep~ doses of vitamin A and/or f-carotene
were
e,.ee -rn~trnr ealth administered [vitamin A, 200,000 IU/
~~~week/6 months (3), 100,000 IU/week/3
months (4), 60 mg/week/6 months (5); 1-
carotene, 180 mg/week plus vitamin A
100,000 IU/ week/3 months (4)]. Inter-
estingly, frequency of micronucleated buc-
::2,22, c~~~~~~~~al mucosa cells was the intermediate end-
Point used to estimate the response of the
oraI mucosa to vitamin A or g-carotene,
ith changes seen as early as 1-3 months,
w~hereas modifications in the frequency of
~~~~~preneoplastic leukoplakias required 4-6
.............. X. M~Onths. Epidemiological studies have
s~~~hown a protective effect against certain
ancers (lung, oral cavity, esophagus, stom-
sss-...
a:: : : : - sch, breast, ovary, etc.) when the dietary
'ntake of vitamin A S-carotene is signifi-
--0 cantly increased compared to controls (2).
Retinoids are active in the promotional
phase of carcinogenesis (6), and their
chemopreventive actions are reversible
upon withdrawal, a very important point
for our SWMMC-exposed population,
since theoretically it implies that the sub-
jects have to continue with retinoids or
their precursors for as long as they remain
in the highly polluted urban environment.
Because our final aim is to give the chemo-
prevention treatment for long periods of
time to a large population, including
women and children, the doses ofvitamin
A and f-carotene chosen are low compared
to those used in other clinical trials.
Vitamin E is a well-known antioxidant
that acts in the promotional phase of car-
cinogenesis through its action on free radi-
cals (2,2'). Absence of dietary vitamin E
exacerbates lung injury from ozone inhala-
tion in rats (8). Elsayed et al. (8) found
that the magnitude ofthis protective effect
does not increase proportionately with
increased dietary vitamin E supplementa-
tion beyond a certain level.
The results of our 4-month pilot trial
show no statistically significant difference
between the treated and placebo groups on
the chosen endpoint of nasal dysplasia,
remission of established nasal dysplasias
and/or inhibition of the development of
new dysplasias. Furthermore, we present
evidence of a high correlation coefficient
between nasal dysplasia and polymor-
phonuclear leukocytes (PMNs) revealed by
nasal cytology and also ofa direct relation-
ship between an increment in PMNs in the
nasal turbinates and the total number of
monthly exposure hours to ozone above
0.11 ppm. A theoretical nasal dysplasia
predictor equation is proposed for
SWMMC adult males.
We suggest that the nasal cytological
changes in SWMMC inhabitants may con-
stitute an adaptative response to the urban
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environmental pollutants. A long-term
follow-up of these subjects will be neces-
sary to establish the possible outcomes of
the nasal abnormalities.
Methods
The project was approved by the Medical
Ethical Committee of the Naval Medical
Center, and informed consent was ob-
tained from all subjects. We selected 206
healthy male subjects between 18 and 50
years of age (mean 30.4 ± 7.2 years) for
the study. The participants were health
workers, medical staff, and Marines work-
ing in SWMMC, where they spend . 8 hr
(from 7:00 AM onward), 6-7 days per
week. In addition, 49.75% of these sub-
jects lived in the SWMMC urban area.
We chose this population because of the
many advantages it presented for an inter-
vention project. The subjects were sta-
tioned in an SWMMC area for which we
have atmospheric pollutant data 24 hr per
day, all year long, for several years; their
movements during the day (when the pol-
lutant emissions are at their highest) were
virtually restricted to a few city blocks; the
participants had no known exposures to
local sources of air pollutants; they could
be readily reached to control the intake of
medication; and, finally, they were very
cooperative with researchers. Subjects
were introduced into the study during
November and December 1990, and the
trial ended 4 months later.
Clinical data obtained included age,
sex, place of residence within MMC,
length of residence, occupation, personal
history of allergic diseases, smoking and
drinking habits, and otolaryngologic histo-
ry (epistaxis, nasal dryness, nasal mucous,
nasal obstruction, rhinorrea, and septal
deviation). These latter six clinical vari-
ables form part of the clinico-cytological
variables (CCV) and were scored as ab-
sent, minimal, moderate, or severe. Septal
deviation was scored as absent or present.
We excluded individuals with a history of
surgical otolaryngologic procedures or in
need oftreatment, atopic rhinitis, asthma,
upper respiratory infections, known job
exposure to toxic substances, photocopy-
ing machine workers, cigarette smokers
with a consumption of more than half a
pack per week, subjects traveling to and
from MMC, and those regularly taking
vitamin preparations or undernourished.
The study was a double-blind random-
ized, placebo-controlled, 4-month trial,
and the subjects were divided into 5
groups. All groups received daily doses of
vitamin A (5000 IU), vitamin E (toco-
pheryl acetate; 100 IU), a combination of
vitamins A and B (5000 LU + 100 LU), T -
carotene (16 mg), or placebo (vegetable
oil). All participants were submitted to an
ear-nose-throat examination by an oto-
laryngologist three times during the study
period: days 0, 60, and 120. The ENT
findings, upper respiratory symptomatol-
ogy and medication side effects were
recorded; the administration of the desig-
nated doses was closely monitored through-
out.
Cytology Sampling
After the rhinoscopic examination, we
scored the severity of the nasal mucosa
findings by reference to five parameters
(CCV); atrophy, hyperemia, hyaline
mucous bridges, bleeding friable mucosa,
and pale mucosa (1 = absent to 4 = se-
vere). The nasal cytology specimen was
taken by the same physician from behind
the anterior curvature of the inferior
turbinate of the nasal cavity with the best
airflow passage. The second and third
samples were obtained from the same side
as the original one. A small piece of a
wooden tongue depressor was used to take
the cytology sample. We obtained two
slides from each subject, and Papanicolau-
stained slides were prepared and examined
by two pathologists separately,with no
access to clinical information. The follow-
ing cytological parameters were scored: cil-
iated respiratory-type cells, goblet cells,
squamous metaplasia cells, inflammatory
cells, and dysplasia (Figs. 1-4). For the
first three parameters, the scoring system
was 1 = absent, 2 = 1-25%, 3 = 26-50%,
4 = 51-75%, and 5 = >76%. The last two
parameters were scored absent, mild, mod-
erate, and severe. In 86% ofthe cases, the
scores of both observers coincided; in the
.,~~~~~~~~~M ......... . . . ............. B, , ..... -.
Figure 2. Respiratory cells in profile. Note the
distal terminal plates with loss of cilia and the
thin, whiplike, elongated proximal ends. The
chromatin appears faintly granular. Oil immer-
sion; -lOOOx.
Figure 3. Cluster of cells. Note the three squa-
mous metaplastic cells with mild atypia and an
isolated, regular squamous metaplastic cell. Oil
immersion; -550x.
4?fr.,. '
Figure 1. Nasal cytology smear taken from the
inferior turbinate shows ciliated respiratory type-
cells and goblet cells. The mucus-producing gob-
let cells (arrow) display a distended cytoplasm
and a peripherally located nucleus. Papanicolau-
stained; 200x.
remaining cases, the samples were reexam-
ined, and a joint determination of the
appropriate score was reached. Only the
results of the first and the third clinical
and cytological evaluations are considered
here.
In this study, the endpoint for assess-
ing chemical intervention was dysplasia:
remission of established nasal dysplasias
and/or inhibition of the development of
new dysplasias. The criteria ofcytological
dysplasia was made on the bases of the
identification of dysplastic cells exhibiting
mild to severe pleomorphism, both in the
size and shape ofcells and their nuclei, as
well as alterations in the staining charac-
teristics.
StatisticalAnalysis
We used Student's t-test, analysis of vari-
ance with contrast, Fisher's least significant
difference test, Cochran-Mantel-Haenszel
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Figure 4. Cluster of markedly atypical cells. Note
the large, irregularly shaped, densely hyperchro-
matic nuclei. Oil immersion; -lOOOx.
chi-square test, and multivariate linear
regression analysis for statistical analysis.
For the development ofthe theoretical dys-
plasia predictor equation, multivariate lin-
ear analysis was used. Only p < 0.05 was
considered significant.
Results
Air Quality Data
Ozone (03) has been monitored continu-
ously at the Atmospheric Science Center
(located in SWMMC) since 1979 and not
until 1981 were diurnal levels of03 > 0.11
ppm recorded: 40 and 30 hr of 03 > 0.11
ppm were recorded in 1984 and 1985,
respectively. The number of hours
SWMMC inhabitants are exposed to 03 >
0.11 ppm has been steadily increasing since
September 1986 and coincided with the
marked decrease oftetraethyl lead in MMC
gasoline. For 11 ofthe 12 months of 1990
and for every month in 1991, more than
85 hr of03 > 0.11 ppm were recorded, for
a total of 1403 hr in 1990 and 1561 hr in
1991 (Table 1). In fact, there were only 6
days in 1991 with diurnal levels of 03 <
0.11 ppm. A similar trend has been ob-
served in the monthly average of maximal
concentrations of 03 recorded in
SWMMC (Table 2): during 1990 and
1991 the maximum levels were mostly
above 0.2 ppm, with the highest levels (>
0.5 ppm) recorded in October 1991.
Concentrations of sulfur dioxide in
SWMMC for the years 1990-1991 have
shown a diurnal cycle with maxima in the
morning hours and in the winter months;
however, the EPA Air Quality Standard of
30 ppb annual average for sulfur dioxide is
not exceeded in SWMMC. Formaldehyde
levels in SWMMC show a peak shortly
before noon, and in samples taken between
Table 1. Number of hours with ozone levels
above 0.11 ppm, per month, 1987-1991, southwest
metropolitan Mexico City
Month 1987 1988 1989 1990 1991
January 56 48 77 129 1Ola
February 33 92 57 85 115a
March 35 39 65 55 144a
April 21 64 113 104 131
May 48 77 144 177 186
June 46 51 133 118 139
July 31 93 93 106 134
August 88 66 100 126 142
September 99 104 54 98 84
October 116 111 139 121 119
November 71 104 145 139a 130
December 96 110 104 145a 136
Total 740 959 1224 1403 1561
a Intervention trial months.
Table 2. Monthly average of maximal concentra-
tions of ozone (ppm), 1986-1991, southwest met-
ropolitan Mexico City
Month 1986 1987 1988 1989 1990 1991
January 0.072 0.136 0.145 0.167 0.210 0.170a
February 0.060 0.110 0.190 0.141 0.180 0.200a
March 0.057 0.103 0.122 0.155 0.140 0.210a
April 0.065 0.113 0.168 0.190 0.220 0.200
May 0.055 0.133 0.164 0.220 0.280 0.252
June 0.039 0.122 0.134 0.250 0.200 0.220
July 0.043 0.122 0.184 0.190 0.200 0.230
August NR 0.174 0.158 0.190 0.210 0.230
September 0.144 0.176 0.189 0.180 0.210 0.190
October 0.190 0.205 0.176 0.220 0.200 0.250
November 0.120 0.160 0.177 0.210 0.220a 0.220
December 0.123 0.170 0.189 0.170 0.220a0.200
NR, ozone values not recorded.
aTrial months.
10:30 AM and 12:30 PM, the mean average
is 0.021 ppm (25.66 ig/m3; data from
October 1987 to February 1988). In the
study period from November 1990 to
March 1991, the mean average of formal-
dehyde was of0.03 ppm (44,g/m3).
StudyPopulation
Ofthe initial 206 subjects, 177 were moni-
tored throughout the 4-month trial; 29
subjects were excluded due to changes in
work location. The participants had a mean
length of residence in MMC of 165 ± 143
months (46% of them had < 72 months
and 54% > 72 months residence in MMC);
only 19 participants had less than 1 year of
residence in MMC (5.94 ± 2.8 months).
There were no statistical differences
among groups at day 0 in regard to clinical,
otolaryngological, and nasal cytology find-
ings. No attempt was made in this study to
determine the indoor/outdoor exposure
schedule or the level ofphysical exercise of
the participants, although the majority
spent most of their working time indoors
and were in the category of intermittent
light and moderate physical exercise. No
medication side effects were reported.
We grouped the subjects in terms of
their cytological dysplasia and their chemo-
prevention treatment (Table 3). Sixteen
clinical and cytological variables were eval-
uated at days 0 and 120, and their score
increments or decrements were determined
at the end of the trial in this manner:
ACCV= CCV2 - CCV1 , where ACCV
represents the increment or decrement (>
0, < 0) between the two evaluations at the
beginning and end of the trial. We then
determined, by multivariated linear regres-
sion analysis, that 3 of the 16 CCVs stud-
ied had the highest correlation coefficients
with cytological dysplasia: PMNs (0.76),
SM (0.554), and NMA (0.515). These
parameters were independent variables
(correlation coefficients SM:PMNs, 0.162;
SM:NMA, 0.085; PMNs; NMA 0.01660).
The distribution of individual subjects by
cytological dysplasia, chemoprevention
treatment, and decrements or increments
in the three important variables that corre-
late with dysplasia is available upon re-
quest. The sum of the increments or
decrements in PMNs, SM, and NMA was
designated "expected dysplasia" (eD). The
response rate of the four treated groups
versus the placebo was evaluated in terms
of cytological dysplasia at the end of the
trial, and no statistically significant differ-
ence was found; data in Table 3 were
assessed by analysis of variance (Ftest, F.
0.0199 < 2.87 and F, 0.89 < 2.84 ). Nor
was there any difference in cytological dys-
plasia when we analyzed the data, regard-
less oftreatment: At day 0, 91 subjects had
dysplasia [51.41%: 72 (79.12%) mild, 19
(20.87%) moderate] and at day 120, 90
subjects had dysplasia [51%: 75 (83.33%)
mild, 13 (14.44%) moderate, and 2
(2.22%) severe].
Most subjects, regardless of treatment,
showed an increased severity of squamous
metaplasia (p < 0.01), nasal mucosa atro-
phy (p = 0.012), mucosal hyperemia, a
decrease in the numbers ofciliated respira-
tory-type cells, and a decrease in the
amount of nasal mucus (p = 0.0073).
There were no changes in epistaxis and
bleeding friable mucosa. A statistically sig-
nificant difference in nasal symptomatol-
ogy was present in the group receiving vita-
min A in regard to nasal dryness (p =
0.01372) and nasal obstruction (p =
0.02155) and in the group receiving f3-
carotene in regard to nasal dryness (p =
0.0072). On the other hand, the placebo
group showed a significant worsening in
nasal dryness and nasal obstruction (p <
0.01). No differences were seen in terms
ofdysplasia or CCVs between nonsmokers
and smokers (p = 0.267). The 19 subjects
with less than 1 year ofresidence in MMC
showed a high correlation coefficient
between squamous metaplasia and de-
creased nasal mucus (0.60) and between
length of residence in months and expect-
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Table 3. Subjects groups in terms of cytological dysplasia, chemoprevention treatment, and length of
residence in Mexico City
Treatment Dysplasia groupb No. of
groupsa GI Gil Gill GIV GV GVI patients
Gl 11 7 7 10 0 2 37
G2 5 7 9 11 0 2 34
G3 10 9 7 4 1 0 31
G4 5 4 13 11 1 2 36
G5 10 8 8 10 1 2 39
Residence
>1 year 40 32 39 38 2 7 158
<1 year 1 3 5 8 1 1 19
Total no. 41 35 44 46 3 8 177
of patients
aGI, vitamin E; G2, vitamin A; G3, vitamins A and E; G4,1-carotene; G5, placebo. bGl, subjects without dysplasias throughout the study; Gil, subjects with dysplasias that did not change
throughout the study; Gill, subjects who went from no dysplasia to dysplasia atthe end ofthe study; GIV,
subjects who started with dysplasia, but had no dysplasia atthe end ofthe study; GV, subjects who went
from a low degree of dysplasia to a higher degree of dysplasia; GVI, subjects who went from a high
degree of dysplasia to a lower degree.
ed dysplasia (0.51). Furthermore, only 1
ofthe 19 newly arrived subjects showed no
dysplasia during the 4-month observation
period; the remaining 18 individuals occu-
pied a place in each ofthe cytological dys-
plasia groups (Table 3).
Theoretical Nasal Dysplasia
Predictor Equation
Based on the observation of high correla-
tion coefficients between three CCVs and
cytological dysplasia, the following equa-
tion was applied as a model:
uD(unadjusted dysplasia) =
0.76APMNs + 0.55 ASM + 0.52 ANMA (1)
where APMNs, ASM, and ANMA repre-
sent the changes (increments or decre-
ments) in these variables at the end of the
4-month observation period. Subsequent-
ly, the equation was written as follows:
tD(adjusted, theoretical dysplasia) =
NAPMNs + K2 ASM + K3 ANMA + K4(2)
where K1, K2 and K3 are adjusted con-
stants based on the original correlation
coefficients between the pertinent CCV
data, and K4 is a proportionality constant;
this leads to a proposed final form:
tD = 0.85 APMNs + 0.50 ASM
+ 0.41ANMA + 0.98. (3)
Correlation coefficients for SM and NMA
are lower after adjustment, while the value
increased for PMNs. Figure 5 shows the
tD scores versus increments or decrements
over time of squamous metaplasia (ASM)
and polymorphonuclear leukocytes
(APMNs).
We then analyzed eDand tD in relation
to cytological dysplasia and determined
that the majority of subjects without dys-
plasia throughout the study and subjects
who started with dysplasia but who had no
dysplasia at the end ofthe study correspond
to negative or low positive score ranges (eD,
-2-0 and tD, -0.28-1.50). Subjects with
dysplasia that did not change throughout
the study are in the middle of the scale,
and subjects who went from no dysplasia
to dysplasia at the end of the study corre-
spond to the highest score ranges (eD, 3,4
and tD, >2.51). Theoretical dysplasia
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scores in relation to cytological dysplasia
are shown in Table 4. Note that there are
a certain number of subjects who display
high tD scores in spite of the absence of
cytological dysplasia (the 13 subjects in GI
with tD values between 1.51 and 2.50),
and the GII individuals with dysplasia that
did not change throughout the study had
tDvalues of2.51-3.50 (n = 9). The impli-
cations ofthese findings are complex. On
one hand, this relationship between cyto-
logical dysplasia and low or high tD scores
could indicate the predictive value of the
equation; namely, subjects without cyto-
logical dysplasia after two evaluations but
with high tD scores are at risk ofdevelop-
ing cytological dysplasia in the future, and
the subjects with a steady dysplasia perhaps
will go into a higher severity ofdysplasia if
their tD values remain high over a period
of time. This prediction must be con-
firmed by periodical cytological exams in
the same subjects. On the other hand, we
have to take into account the inherent flaw
in cytological procedures; that is, the pres-
ence of false positives or negatives. Long-
term follow-up of these individuals will
clarify these issues.
It is interesting to point out here that
the correlation coefficient between resi-
Figure 5. Theoretical dysplasia (tD) scores versus increments or decrements over time of squamous
metaplasia (ASM ) and polymorphonuclear leukocytes (APMNs). Data based on the equation: tD = 0.85
APMNs + 0.50ASM + 0.41 ANMA + 0.98.
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Table 4. Theoretical dysplasis (to) scores and cytological dysplasia groups
Dysplasia groupa No. of
tD G6 GIl Glil GIV GV GVI patients
-0.28-0.54 2 4 4 12 0 3 25
0.55-1.50 25 7 6 22 1 3 64
1.51-2.50 13 15 14 5 2 2 51
2.51-3.50 1 9 19 5 0 0 34
>3.51 0 0 1 2 0 0 3
aSee Table 3 for a description of dysplasia groups.
Higher scores are seen in subjects with persistent dysplasia (GIl) and for subjects who wentfrom no dys-
plasia to dysplasia atthe end ofthe study(Gill).
dence in months and tD scores in the
group of 19 subjects with less than 1 year
ofresidence in MMC was 0.66. This rela-
tionship holds true for all subjects who had
lived less than 20 months in MMC; it did
not hold true, however, for individuals
with more than 10 years in MMC (data
not shown). Further, 65% ofsubjects with
high tD scores had lived less than 72
months in MMC, whereas 61% ofsubjects
with low scores had lived more than 72
months in MMC. The 72-month division
is crucial because it marks the abrupt
change in diurnal ozone values in
SWMMC (Table 2).
In an attempt to correlate PMN values
for the population studied with actual 03
values during the study period, we estab-
lished two points: P2 (x = 128.8, y = 48),
where the value on the abscissa corre-
sponds to the average number of hours
with 03 > 0.11 ppm over the 5-month
study period (November 1990 through
March 1991; see data in Table 1) and the
value on the ordinate corresponds to the
percentage of patients at the end of the
study with APMNs > 0 (48%) and PI (x =
113.8, y = 42.42), where 113.8 corre-
sponds to the average number of hours
with 03 > 0.11 ppm during the 5 months
before the study (June through October
1990), and 42.41 represents the percentage
ofsubjects living in SWMMC assumed to
have developed an increment in PMNs,
based on the P2 value. The straight line
PI-P2 can be prolonged, and we estab-
lished a presumptive 03 value when 50%
of the SWMMC population has an incre-
ment of PMNs in their nasal turbinates;
this value corresponds theoretically to 130
hr in a month with ozone values above
0.11 ppm (a rather common situation in
SWMMC).
Discussion
This study is the first double-blind,
placebo-controlled trial with low oral doses
of vitamins A, E, and f-carotene adminis-
tered to individuals chronically exposed to
photochemical smog, ofwhich ozone is the
most important constituent. Nasal dyspla-
sia was the chosen endpoint ofthe study.
As reviewed by Bertram et al. (2), vita-
min A and retinoids allow normal growth
and epithelial differentiation and have
well-demonstrated effects on the inhibition
ofexperimental and human carcinogenesis
at several sites, including the oral cavity
(3-5). In a population ofbetel quid chew-
ers in India, a 6-month treatment with oral
vitamin A (200,000 IU/week) induced
remission of established oral leukoplakias
in 57% of patients, preventing the forma-
tion of new leukoplakias within the trial
period (4). Beta-carotene also has chemo-
preventive and antitumor activity (4-6).
Both vitamin A and f-carotene are active
in the promotional phase ofcarcinogenesis;
there is a delay in tumor onset with a slow-
down in the progression to frank neoplasia
(2). Vitamin E, on the other hand, is a
lipid-phase antioxidant that inhibits cellu-
lar damage produced by oxygen free-radi-
cals and is also active in the promotional
phase ofcarcinogenesis.
The results ofthis study show no effect
on dysplasia with any of the vitamins or
the fl-carotene-neither remission of
established nasal dysplasias nor inhibition
ofthe development of new ones. Further,
we found a worsening of squamous meta-
plasia in all patients, regardless of treat-
ment, with only a few improved clinical
parameters in treated subjects. The fact
that no positive results were seen might be
result ofthe short trial time and the lack of
interim endpoints; positive effects on
chemoprevention results will have to be
studied in a larger number ofsubjects over
a longer period. More importantly, how-
ever, this study allowed us to establish a
relationship between nasal dysplasia and
clinico-cytological variables that show
increments in relation to high levels of
ozone in the polluted SWMMC atmos-
phere.
Ozone injury involves the development
of oxygen free-radical events, which are
responsible for DNA strand breaks and the
formation of base adducts such as 8-
hydroxyguanine (9). Borek et al. (10),
using in vitro transformation, reported that
03 induced neoplastic transformation in
primary hamster embryo cells and mouse
fibroblast cultures, with enhanced levels of
free-radical-mediated lipid peroxidation
products. Borek at al. (10) concluded that
"ozone acts as a direct carcinogen and co-
carcinogen on susceptible cells, therefore
having important consequences for public
health."
The nasal cavity absorbs 40-70% of
inhaled ozone in dogs (11) and is a major
target for environmental pollutants. Ex-
posure of rats to 0.8 ppm 03 for 3 or 7
days results in hyperplasia of the nasal
cuboidal transitional epithelium; the rat
cuboidal transitional epithelium is the
epithelial cell type most responsive to the
effects of03 exposure (12). Johnson et al.
(12) encountered a variable response to
ozone depending on concentration, dura-
tion of exposure, and cell type; these
authors suggest that there is an immediate
proliferative response to ozone (within 3
days) which then subsides and is followed
by the development ofhyperplastic lesions.
Similar changes are described in the transi-
tional and respiratory nasal epithelia in the
Bonnet monkey after 6 days ofexposure to
0.15 ppm 03 (13). Further, three 6-hr/
day exposures to 0.8 ppm 03 in rats trig-
gered hyperplastic and metaplastic changes
in the nasal nonciliated cuboidal epitheli-
um (14). As reported earlier, basal cell
hyperplasia and squamous metaplasia are
seen in human nasal biopsies of subjects
exposed for more than 2 months to levels
of03 > 0.11 ppm (1). In the nasal biopsy
study we observed in some cases an acute
inflammatory intraepithelial infiltrate as
well as marked proliferation of capillaries
in or against basement membranes, and
submucosal proliferation of thin vascular
channels. Hotchkiss et al. (15 ) reported
large numbers of pavementing neutrophils
within nasal turbinate blood vessels in rats
exposed to 0.8 ppm 03 immediately and
18 and 66 hr after exposure, although they
did not mention increased numbers ofsub-
mucosal blood vessels. The same authors
demonstrated that a single 6-hr exposure
to 03 (0.12 and 0.8 ppm) induces an
inflammatory response within the rat nasal
cavity; furthermore, the number of PMNs
recovered by nasal and bronchoalveolar
lavage (NAL and BAL), accurately reflect-
ed the inflammatory response in the nasal
cavity and lungs injured by the acute ozone
toxicity. Human exposures to 0.4 ppm 03
for 2 hr elicit a 7.7-fold increase in PMN
in NAL (immediately postexposure), and
this increase is detectable 18 hr later (6-
fold), both in NAL and BAL (16).
In the present study, the percentage of
patients with PMNs in their nasal cavity,
regardless of treatment, was 60% at day 0
and 81% at day 120, and 48% ofsubjects
showed an increment in PMNs at the end
ofthe 4-month observation period. These
results are in agreement with previous
observations both in rats and humans
(14-16) that exposures to 03 > 0.12 ppm
(the current U.S. Air Quality Standard for
Environmental Health Perspectives 142A -
.99 I-
- * 1
03) induce an inflammatory nasal re-
sponse. Because SWMMC inhabitants are
exposed an average of 4.27 hr/day/359
days a year (1991 data) to levels of 03 >
0.11 ppm, there is absolutely no possibility
of a decrease in the number of PMNs in
their upper and lower respiratory airways.
Ifwe further observe that the development
ofnasal epithelial phenotypic changes does
not require continuous 03 exposure (14),
we have the appropriate conditions for the
development of hyperplastic, metaplastic,
and dysplastic nasal lesions. The high cor-
relation coefficient between nasal dysplasia
and PMNs is an interesting but not sur-
prising finding in view ofthe previous sug-
gestion that release of neutrophil products
is an inductive mechanism for secretory
cell hyperplasia and metaplasia in 03-
exposed macaque nasal epithelium (17)
and the considerable evidence that libera-
tion or generation of oxygen free radicals
contribute to carcinogenesis (9,18-26).
Dysplastic nasal mucosa lesions in
SWMMC inhabitants may well be a mani-
festation ofa process ofadaptation to pro-
longed exposure to environmental atmos-
pheric pollutants.
Farber and Rubin (27) make several
points that could be relevant to this study:
carcinogenic agents produce heritable
changes in a high proportion of treated
cells at both the initiation and promotion
stages, although its obvious manifestations
(e.g., focus-forming capacity, benign
tumors) occur with low probability.
Transformation represents an adaptative
response to growth constraints and occurs
only under specific physiological condi-
tions; the optimal condition for transfor-
mation in vivo being growth stimulation.
Given the evidence of the rapid devel-
opment of nasal dysplasia upon arrival in
SWMMC (1), the question arises how
these pathological changes might be elicit-
ed and what role ozone plays. Farber and
Rubin (22) state that "the persistent per-
turbation of the concentration or localiza-
tion in cells of proteases and other hydro-
lytic enzymes might result in a transmissi-
ble defect of growth regulation." In this
regard, phagocytic cell activation and the
resultant host of mediator substances
(including proteases, oxidants, neuropep-
tides, etc.) are both markers and effectors
of toxin-induced respiratory tract injury
(15,16,22).
We propose that repeated, chronic
exposures to 03 and other toxic and
potential carcinogenic atmospheric pollu-
tants in SWMMC trigger a series ofadap-
tative responses in the nasal mucosa, char-
acterized histologically by severe loss of
normal mucociliary epithelium, basal cell
hyperplasia, squamous metaplasia, focal
atrophy of the mucosa, and atrophy of
submucosal glands [with a consequent
decrease in mucus and antioxidant protec-
tion (28)], submucosal vascular prolifera-
tion and telangiectatic blood vessels [the
result, perhaps, ofthe activation of type C
sensory nerves and the release ofneuropep-
tides (22)], activation of monocytes and
macrophages in the submucosa, and mild
to severe dysplastic changes, with nasal
dysplasia highly correlated with the incre-
ment ofPMNs in the nasal cavity.
Subjects newly arrived in SWMMC
rapidly display these pathological changes,
and in less than 1 year they can be includ-
ed in cytological dysplasia groups. These
groups, far from being static, undergo rela-
tively rapid changes, some toward a higher
degree ofatypia (two severe dysplasias were
diagnosed during the 4-month observation
period), others toward an apparent rever-
sibility of the phenotypic changes. Al-
though the cytological dysplasia groups
seem to be well characterized, the applica-
tion of the theoretical dysplasia equation
reveals that some apparently phenotypical-
ly "nonatypical" nasal mucosas are at high
risk of developing atypical, dysplastic
lesions at a later time.
The theoretical dysplasia equation has
been developed to encourage a systematic
clinical and cytological approach for analy-
sis and presentation of risk estimates in
nasal samples taken from a well-character-
ized SWMMC population exposed to pho-
tochemical smog. Long-term follow-up of
these populations will be necessary to
establish the real value ofthe equation and
several other elements ought to be added:
exposures, doses, and lifetime individual
risk ofvarious indoor and outdoor air pol-
lutants of a carcinogenic and toxic nature
(29).
The possible outcomes ofthe cytologi-
cal nasal findings described in this popula-
tion remain unclear at this point. The
spectrum of cytological and histological
abnormalities in the nasal turbinates varies
from benign reactive changes to lesions
characterized by nuclear abnormalities
such as enlargement, hyperchromasia, and
disturbances of mitotic activity. We have
already encountered severe dysplasias and
in one case an squamous cell carcinoma in
situ; however, the incidence of nasal squa-
mous cell carcinoma remains low, at least
in the reported cases to oncological hospi-
tals in Mexico City. We suspect that this
incidence could increase in the next few
years if the problem of urban pollution
continues to be severe.
Finally, although ozone is the focus of
our investigation, other toxic and carcino-
genic substances in the SWMMC may play
a role in the nasal mucosa changes de-
scribed here. In particular, formaldehyde
can produce proliferative reactions such as
hyperplastic-metaplastic lesions in xeno-
transplanted human nasal respiratory
epithelium (30) and squamous cell carci-
nomas in the rat nasal cavity (31). Further
work is urgently needed to determine the
effect. of environmental pollutants in
SWMMC inhabitants. Well-characterized
groups of subjects should be monitored
and have the benefit ofa close follow-up of
nasal mucosa changes.
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Alitfle reminderfrom the Environmental Defense Fund
that ifyou're notrecycling, you're throwing away a lot more
than justyourtrash.
You andyourcommunitycanrecycle. Write the Environ-
mentalDefense Fund at: EDF-Recycling, 257 ParkAvenue
South, NewYork, NY10010, for afree brochure thatwilltell
you virtually everything you w
need to know about recycling. t JT
) 1988 EDF
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